US 9102940
RNAi modulation of SCAP and therapeutic uses thereof
granted A61PA61P1/00A61P1/16
Quick answer
US patent 9102940 (RNAi modulation of SCAP and therapeutic uses thereof) held by The Board of Regents of the University of Texas System expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P1/00, A61P1/16, A61P3/00, A61P3/04